等待开盘 06-22 09:30:00 美东时间
-0.058
-6.76%
An update from TELA Bio ( ($TELA) ) is now available. TELA Bio reported first q...
05-13 04:43
TELA Bio (NASDAQ:TELA) FY2026 Revenue expected to be more than $86.697M vs $86.849M Est
05-13 04:09
TELA Bio (NASDAQ:TELA) sees Q2 sales of $20.000 million vs $21.043 million analyst estimate.
05-13 04:08
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
TELA Bio shares are trading higher after the company reported preliminary Q1 sa...
05-02 01:59
今日重点评级关注:花旗:维持Biomea Fusion"买入"评级,目标价从6美元升至7美元;Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.75美元升至8.25美元
03-30 11:49
今日重点评级关注:HC Wainwright & Co.:维持OCUGEN"买入"评级,目标价从7美元升至10美元;HC Wainwright & Co.:维持Maze Therapeutics"买入"评级,目标价从60美元升至110美元
03-26 11:41
TELA Bio (NASDAQ:TELA) reported mixed Q4 results, with higher losses but lower sales than expected. Analysts lowered price targets for the stock.
03-26 04:37
Top analysts change outlook for top names. Citigroup, Tigress Fin, Piper Sandler, Morgan Stanley, HC Wainwright, Susquehanna, Raymond James and Goldman Sachs adjust price targets for companies like Braze, Amazon, TELA Bio, Smithfield Foods, Corcept Therapeutics, TechnipFMC, Phillips 66, and KB Home. See all changes at benzinga.com/analyst-stock-ratings.
03-26 04:11
Canaccord Genuity analyst Caitlin Roberts maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $4 to $2.
03-25 22:00